| 000 | 00868cam a22002534a 4500 | ||
|---|---|---|---|
| 999 |
_c7601 _d7601 |
||
| 001 | 12917 | ||
| 003 | BD-DhUAP | ||
| 005 | 20210125145448.0 | ||
| 008 | 010131s2004 coua b 001 0 eng c | ||
| 040 |
_aDNLM/DLC _cDLC _dBD-DhUAP _beng |
||
| 082 | 0 | 0 |
_a615.14 PHA _223 |
| 245 | 0 | 0 |
_aPharmaceutical preformulation and formulation : _ba practical guide from candidate drug selection to commercial dosage form / _cedited by Mark Gibson. |
| 260 |
_aLondon : _bInterpharm/CRC, _cc2004. |
||
| 300 |
_axi, 596 pages : _billustrations ; _c26 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aDrugs _xDosage forms. |
|
| 650 | 1 | 2 | _aDrug Compounding. |
| 650 | 2 | 2 |
_aBiopharmaceutics _xmethods. |
| 650 | 2 | 2 |
_aChemistry, Pharmaceutical _xmethods. |
| 650 | 2 | 2 | _aDosage Forms. |
| 650 | 2 | 2 | _aDrug Evaluation. |
| 700 | 1 | _aGibson, Mark. | |
| 942 |
_2ddc _cBK |
||